1. Short title This Act may be cited as the Medical Innovation Never Stops Act of 2019 . 2. Authority during a lapse in appropriations Chapter VII of the Federal Food, Drug, and Cosmetic Act is amended by inserting after section 738A ( 21 U.S.C. 379j–1 ) the following: 738B. Authority during a lapse in appropriations (a) Acceptance of submissions and registrations; application of fees During any period in which appropriations are not in effect for the Food and Drug Administration, the Secretary shall— (1) accept a submission described in section 738(a)(2) and a registration described in section 738(a)(3) if an applicable fee has been submitted for such submission or registration; (2) collect such fees in accordance with this part, notwithstanding any limitation with respect to the availability of appropriations in section 738; and (3) obligate and expend such fees as may be so collected for the process for the review of device applications. (b) Application of previously paid fees (1) In general During any period in which appropriations are not in effect for the Food and Drug Administration, the Secretary may obligate and expend for the process for the review of device applications any fees— (A) that were paid before such period began for submissions described in section 738(a)(2), but with respect to which a submission has not been received